Safety and Efficacy of Amniotic Cytokine Extract in the Treatment of Dry Eye Disease

Purpose: Evaluate the safety and efficacy of cryopreserved amniotic cytokine extract (ACE) in the treatment of subjects with dry eye disease


Pre-Sale Begins Today for Amnion-Derived Drops to Comfort Dry Eyes

New biologic products from Regenerative Science – Genesis 2.0, ACE and Renaissance – contain mixture of more than 120 cytokines, proteins, and growth factors.


Ocular Science Launches Two Affiliates to Focus on Compounding and Biologic Sectors

Ocular Science launches two affiliates to focus on compounding and biologic sectors of ophthalmic market.


ASCRS FDA Committee Member Speaks on Access to Compounded Drugs

ASCRS FDA committee member Damien Goldberg, MD, urges FDA to allow access to compounded drugs from traditional compounders without a patient-specific prescription.


Biologics in the Dry Eye Mix 

Many dry eye patients respond well to traditional therapies such as Restasis (cyclosporine, Allergan, Dublin, Ireland) and Xiidra (lifitegrast, Shire, Lexington, Massachusetts).